Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine productionDianji Tu, Shiming Yang, Lulu Cheng et al.|Clinical and Molecular Hepatology|2025Cited by 6
Changes of gut microbiota and short chain fatty acids in patients with Peutz–Jeghers syndromeAn Zhou, Shiming Yang, Bo Tang et al.|BMC Microbiology|2023Cited by 5
Gut microbiome alterations and hepatic encephalopathy post-TIPS in liver cirrhosis patientsShengpeng Li, Bo Tang, Zhengguo Xu et al.|Journal of Translational Medicine|2025Cited by 3